Stony Brook Heart Institute’s Center for Advanced Lipid Management has achieved a historic global milestone, becoming the first center in the world to administer a commercial dose of plozasiran, the newly approved RNA...
For the estimated 1.6 million Americans diagnosed with symptomatic tricuspid valve regurgitation each year, a significant advancement in treatment is now available on Long Island. With the launch of the new...
Stony Brook Medicine is the first on Long Island — and one of a select number of healthcare systems nationwide — to implement an artificial intelligence (AI) technology, HeartFlow Plaque Analysis™, to enable its...
The PerQseal® device is the first sutureless, fully absorbable intravascular 'patch' that seals an artery from the inside after heart valve repair or replacement.
The first of its kind in Suffolk County, the center will use testing tailored to each patient to get a complete understanding of inflammatory markers, lipid profile, apolipoprotein B levels and more.
The new space is part of the Heart Institute, and it consolidates comprehensive cardiac cath and EP services into one shared and efficient increased-capacity location.